← All Sponsors
SPONSOR

Ashibio Inc

Total Trials
1
Recruiting
1
Phases
Phase 1, Phase 2
Conditions studied: Heterotopic Ossification (HO)
NCT07024407 Phase 1, Phase 2
Recruiting

A Study of Andecaliximab in People With Spinal Cord Injury at Risk for Bone Growth Outside of the Normal Skeleton.

Heterotopic Ossification (HO)
United States View Trial →